Valproic acid teratogenicity in whole embryo culture is not prevented by zinc supplementation
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (6) , 1052-1055
- https://doi.org/10.1016/0006-2952(86)90099-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Selenium, zinc, and copper changes with valproic acidNeurology, 1984
- Non‐Dose‐Related Side Effects of ValproateEpilepsia, 1984
- Teratogenic effects of valproic acid and diphenylhydantoin on mouse embryos in cultureTeratology, 1983
- VALPROATE, BIRTH DEFECTS, AND ZINCThe Lancet, 1983
- Quantitation of rat embryonic development in vitro: A morphological scoring systemTeratology, 1981
- Teratogenicity of valproic acid: In vivo and in vitro investigationsTeratogenesis, Carcinogenesis, and Mutagenesis, 1981
- Current status of zinc in health and disease states.Archives of Disease in Childhood, 1979
- WHOLE‐EMBRYO CULTURE AND THE STUDY OF MAMMALIAN EMBRYOS DURING ORGANOGENESISBiological Reviews, 1978
- Reduced DNA Synthesis in Zinc Deficiency: Regional Differences in Embryonic RatsJournal of Nutrition, 1977
- Is there a connection between maternal zinc deficiency and congenital malformations of the central nervous system in man?Teratology, 1973